Updated on 17 September 2013
Rise of personalized medicine is pushing genomics researchers to develop efficient data computing platforms
With the increasing trend of genomics analysis and a wave of personalized medicine taking over in healthcare industry, scientific researchers are in need of high computational instruments that enable next generation sequencing for genomics. The complexity and amount of data being generated during DNA sequencing is massive and the daunting task of data analysis require high-performance computing capability in one single platform. The ability to process, analyze, manage and ultimately act on this data is quickly becoming a critical element of a research project.
New aspect of drug discovery
Revolution in DNA sequencing is similar to the early days when printers were introduced. Earlier, the whole University used to have one big printer and it was shared among everyone and just as now every department or individual has his own printer, platform for DNA sequencing is getting more personalized.
In proliferation of DNA sequencing, there is production of huge amount of data and SGI is able to provide computing technology that has ability to handle high velocity, volume and variety of data of these analysis. In DNA sequencing, data is flowing out at a very high rate and one has to deal with the speed in real time avoiding any loss of data, creating a need for assimilating data in a high velocity. The next challenge in DNA sequencing is analysis of the fast outflow of data. In earlier days, in the process of data sequencing and assembly produced huge jumbled up genome that had to be manually arranged with the help of references. This has been a daunting task for researchers as it is a highly complicated and complex procedure. SGI has developed high performance computing technology that accelerates speed of data storage at one place and enables researchers to do smooth analysis.
Another area where computational technology by SGI is playing a key role is analysis of the drugs developed in labs. Currently, when a drug is developed, it is normally designed for across the population. Concept of personalized medicine is making researchers realize that everybody respond differently to each drug and each individual responds differently to a drug over a period of time. Hence, genomic analysis enabled by SGI plays a role in understanding the reaction of each drug in a human being over a different period of time. If the drug discovery companies are able to analyze this difference, it is easy to understand the response of a drug in future.